Application of peptide receptor radionuclide therapy for gastroenteropancreatic neuroendocrine tumor / 中华消化外科杂志
Chinese Journal of Digestive Surgery
; (12): 763-766, 2018.
Article
en Zh
| WPRIM
| ID: wpr-699196
Biblioteca responsable:
WPRO
ABSTRACT
Peptide receptor radionuclide therapy (PRRT),being investigated as an effective treatment for inoperable gastroenteropancreatic neuroendocrine tumor,has gained much importance in recent years.With increasing data of clinical trials and the exploration of different radionuclides as well as the toxic and side effects,PRRT has developed continuously and play a marked role on the treatment of gastroenteropancreatic neuroendocrine tumor.
Texto completo:
1
Base de datos:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Digestive Surgery
Año:
2018
Tipo del documento:
Article